Predictive validation of existing bleeding and thromboembolic scores in elderly patients with comorbid atrial fibrillation and acute coronary syndrome

被引:0
|
作者
Hong-Hong ZHANG [1 ,2 ]
Qi LIU [5 ]
Hai-Jing ZHAO [1 ,2 ]
Ya-Ni YU [2 ]
Liu-Yang TIAN [1 ,2 ]
Ying-Yue ZHANG [1 ,2 ]
Zi-Hao FU [1 ,2 ]
Li ZHENG [1 ,2 ]
Yue ZHU [1 ,2 ]
Yu-Han MA [1 ,2 ]
Shuang LI [6 ]
Yang-Yang MA [6 ]
Yu-Qi LIU [2 ,5 ]
机构
[1] Medical School of Chinese PLA
[2] Department of Cardiology & National Clinical Research Center of Geriatrics Disease
[3] Beijing Key Laboratory of Chronic Heart Failure Precision Medicine  4. National Key Laboratory of Kidney Diseases, Chinese PLA General Hospital
[4] Department of Cardiology, the Sixth Medical Center,Chinese PLA General Hospital
[5] Department of Information, Chinese PLA General Hospital
关键词
D O I
暂无
中图分类号
R541.75 []; R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The validation of various risk scores in elderly patients with comorbid atrial fibrillation(AF) and acute coronary syndrome(ACS) has not been reported. The present study compared the predictive performance of existing risk scores in these patients.METHODS A total of 1252 elderly patients with AF and ACS comorbidities(≥ 65 years old) were consecutively enrolled from January 2015 to December 2019. All patients were followed up for one year. The predictive performance of risk scores in predicting bleeding and thromboembolic events was calculated and compared.RESULTS During the 1-year follow-up, 183(14.6%) patients had thromboembolic events, 198(15.8%) patients had BARC class ≥2 bleeding events, and 61(4.9%) patients had BARC class ≥ 3 bleeding events. For the BARC class ≥ 3 bleeding events, discrimination of the existing risk scores was low to moderate, PRECISE-DAPT(C-statistic: 0.638, 95% CI: 0.611-0.665), ATRIA(C-statistic:0.615, 95% CI: 0.587-0.642), PARIS-MB(C-statistic: 0.612, 95% CI: 0.584-0.639), HAS-BLED(C-statistic: 0.597, 95% CI: 0.569-0.624)and CRUSADE(C-statistic: 0.595, 95% CI: 0.567-0.622). However, the calibration was good. PRECISE-DAPT showed a higher integrated discrimination improvement(IDI) than PARIS-MB, HAS-BLED, ATRIA, and CRUSADE(P < 0.05) and the best decision curve analysis(DCA). For thromboembolic events, the discrimination of GRACE(C-statistic: 0.636, 95% CI: 0.608-0.662) was higher than CHA2DS2-VASc(C-statistic: 0.612, 95% CI: 0.584-0.639), OPT-CAD(C-statistic: 0.602, 95% CI: 0.574-0.629) and PARIS-CTE(C-statistic: 0.595, 95% CI: 0.567-0.622). The calibration was good. Compared to OPT-CAD and PARIS-CTE, the IDI of the GRACE score slightly improved(P < 0.05). However, NRI analysis showed no significant difference. DCA showed that the clinical practicability of thromboembolic risk scores was similar.CONCLUSIONS The discrimination and calibration of existing risk scores in predicting 1-year thromboembolic and bleeding events were unsatisfactory in elderly patients with comorbid AF and ACS. PRECISE-DAPT showed higher IDI and DCA than other risk scores in predicting BARC class ≥ 3 bleeding events. The GRACE score showed a slight advantage in predicting thrombotic events.
引用
收藏
页码:330 / 340
页数:11
相关论文
共 50 条
  • [21] Predictive Value of Thromboembolic Risk Scores Before an Atrial Fibrillation Ablation Procedure
    Floria, Mariana
    De Roy, Luc
    Xhaet, Olivier
    Blommaert, Dominique
    Jamart, Jacques
    Gerard, Marina
    Dormal, Fabien
    Deceuninck, Olivier
    Ambarus, Valentin
    Marchandise, Baudouin
    Schroeder, Erwin
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (02) : 139 - 145
  • [22] Is dual therapy the correct strategy in frail elderly patients with atrial fibrillation and acute coronary syndrome?
    Alessio Menditto
    Roberto Antonicelli
    Journal of Geriatric Cardiology, 2020, 17 (01) : 51 - 57
  • [23] Is dual therapy the correct strategy in frail elderly patients with atrial fibrillation and acute coronary syndrome?
    Alessio Menditto
    Roberto Antonicelli
    Journal of Geriatric Cardiology, 2020, 17 (01) : 51 - 57
  • [24] Is dual therapy the correct strategy in frail elderly patients with atrial fibrillation and acute coronary syndrome?
    Menditto, Alessio
    Antonicelli, Roberto
    JOURNAL OF GERIATRIC CARDIOLOGY, 2020, 17 (01) : 51 - 57
  • [25] Coronary Angiographyic Findings in Patients of Acute Coronary Syndrome with Atrial Fibrillation
    Majid, Abdul
    Iqbal, Muhahmmad Khaleel
    Faisal, Zeeshan
    Javed, Amir
    Malik, Khalid Razzaq
    Shahid, Muhammad
    Arshad, Anam
    Hussain, Mazhar
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (12): : 3418 - 3420
  • [26] Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
    Lyu, Si-qi
    Zhu, Jun
    Wang, Juan
    Wu, Shuang
    Zhang, Han
    Shao, Xing-hui
    Yang, Yan-min
    THROMBOSIS RESEARCH, 2022, 209 : 16 - 22
  • [27] Atrial fibrillation and acute coronary syndrome
    Potpara, Tatjana
    EUROINTERVENTION, 2024, 20 (16) : 961 - 962
  • [28] Implications of bleeding on subsequent cardiovascular events in patients with atrial fibrillation after acute coronary syndrome or PCI
    Mo, Ran
    Wang, Hao-Yu
    Yang, Yan-min
    Zhang, Han
    Suo, Ni
    Wang, Jing-yang
    THROMBOSIS RESEARCH, 2023, 229 : 243 - 251
  • [29] Bleeding risk assessment in elderly patients with acute coronary syndrome
    Rioboo-Leston, Lucia
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Iniguez-Romo, Andres
    JOURNAL OF GERIATRIC CARDIOLOGY, 2019, 16 (02) : 145 - 150
  • [30] Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome
    Abu-Assi, Emad
    Raposeiras-Roubin, Sergio
    Lear, Pamela
    Cabanas-Grandio, Pilar
    Girondo, Mar
    Rodriguez-Cordero, Marta
    Pereira-Lopez, Eva
    Gestal Romani, Santiago
    Gonzalez-Cambeiro, Cristina
    Alvarez-Alvarez, Belen
    Maria Garcia-Acuna, Jose
    Ramon Gonzalez-Juanatey, Jose
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2012, 1 (03) : 222 - 231